Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Drug treatment as HIV prevention: a research update.

Metzger DS, Woody GE, O'Brien CP.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6. doi: 10.1097/QAI.0b013e3181f9c10b. Review.

2.

Drug treatment as HIV prevention: expanding treatment options.

Metzger DS, Zhang Y.

Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z. Review.

3.

Prevention of HIV infection among injection drug users in resource-limited settings.

Vlahov D, Robertson AM, Strathdee SA.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S114-21. doi: 10.1086/651482. Review.

4.
5.

Illicit drugs, alcohol, and addiction in human immunodeficiency virus.

Samet JH, Walley AY, Bridden C.

Panminerva Med. 2007 Jun;49(2):67-77. Review.

PMID:
17625483
6.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA.

Addiction. 2005 Feb;100(2):150-8. Review.

PMID:
15679744
7.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
8.

Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.

Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E.

Cochrane Database Syst Rev. 2014 May 22;(5):CD004772. doi: 10.1002/14651858.CD004772.pub4. Review.

PMID:
24852077
9.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4. Review.

PMID:
21833948
10.

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS.

Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. Review.

11.

The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.

Altice FL, Sullivan LE, Smith-Rohrberg D, Basu S, Stancliff S, Eldred L.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S178-83. Review.

PMID:
17109304
12.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
13.

Progress in HIV reduction and prevention among injection and noninjection drug users.

Crawford ND, Vlahov D.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S84-7. doi: 10.1097/QAI.0b013e3181fbca5a. Review.

14.

Post-exposure prophylaxis for HIV.

Gerberding JL, Katz MH.

Adv Exp Med Biol. 1999;458:213-22. Review.

PMID:
10549393
15.

Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Review.

PMID:
18646068
16.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
17.

Antiretroviral (ARV) drug resistance in the developing world.

Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, Newberry S.

Evid Rep Technol Assess (Full Rep). 2007 Sep;(156):1-74. Review.

18.

Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.

McCance-Katz EF.

Life Sci. 2011 May 23;88(21-22):953-8. doi: 10.1016/j.lfs.2010.09.016. Epub 2010 Oct 19. Review.

19.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
20.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714

Supplemental Content

Support Center